Xenon Pharmaceuticals Inc.

(XENE) Trade

By |

Profile

Xenon Pharmaceuticals Inc is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological and MAC1.7 inibitors for Pain. Geographically the activities are carried out through Canada.

Contact Information

Website: www.xenon-pharma.com
Email: investors@xenon-pharma.com
Main Phone: +1 604 484-3300
Address: 200-3650 Gilmore Way
State: BC
City / Town: Burnaby
Country: CAN
Postal Code: V5G 4W8

Issuer Information

Exchange: NSD
CEO: Simon Pimstone
Employees: 92
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Xenon Pharmaceuticals Inc is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological and MAC1.7 inibitors for Pain. Geographically the activities are carried out through Canada.

Contact Information

Website: www.xenon-pharma.com
Email: investors@xenon-pharma.com
Main Phone: +1 604 484-3300
Address: 200-3650 Gilmore Way
State: BC
City / Town: Burnaby
Country: CAN
Postal Code: V5G 4W8

Issuer Information

Exchange: NSD
CEO: Simon Pimstone
Employees: 92
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 9.20 $ 0.05 (0.55%)
Last Price 9.20 Change $ 0.05 Change % 0.55 Tick N/A
Bid 9.02 Bid Size 1,000.00 Ask 10.34 Ask Size 100.00
Open 9.16 High 9.33 Low 9.11 Prev Close 9.15
Last Trade Volume 26,139 52 Wk Hi 15.92 52 Wk Low 5.41
Market Cap 237.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 25,772,999.00 EPS (TTM) -1.79 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 42
Number of Buys 1 35
Number of Sells 4 7
Net Activity -2431626 -2092506
Last 10 Buys Shares
Mohammad Azab 1,000
Mohammad Azab 1,000
Mohammad Azab 1,000
Mohammad Azab 1,000
Raymond J. Winquist 1,000
Mohammad Azab 1,000
James R. Empfield 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Michael Hayden 1,000
Last 10 Sell Shares
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Y. Paul Goldberg 1,000
Y. Paul Goldberg 1,000
Y. Paul Goldberg 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 9 9 9 9
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/16/18 05/16/18 05/16/18 05/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1